Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment: results of a randomized extension of the phase III ERASURE and FIXTURE trials

Richard G. Langley; Howard Sofen; Ignacio Dei-Cas; Kristian Reich; Bardur Sigurgeirsson; Richard B. Warren; Carle Paul; Jacek C. Szepietowski; Tsen Fang Tsai; Isabelle Hampele; Ruquan You; Pascal Charef; Charis Papavassilis

doi:10.1093/bjd/ljac040

Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment: results of a randomized extension of the phase III ERASURE and FIXTURE trials

Richard G. Langley, Howard Sofen, Ignacio Dei-Cas, Kristian Reich, Bardur Sigurgeirsson, Richard B. Warren, Carle Paul, Jacek C. Szepietowski, Tsen Fang Tsai, Isabelle Hampele, Ruquan You, Pascal Charef, Charis Papavassilis

Inernational Relations Division

Research output: Contribution to journal › Article › peer-review

19 Citations (Scopus)

Original language	English
Pages (from-to)	198-207
Number of pages	10
Journal	British Journal of Dermatology
Volume	188
Issue number	2
DOIs	https://doi.org/10.1093/bjd/ljac040
Publication status	Published - Feb 2023

ASJC Scopus Subject Areas

Dermatology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/bjd/ljac040

Cite this

Langley, R. G., Sofen, H., Dei-Cas, I., Reich, K., Sigurgeirsson, B., Warren, R. B., Paul, C., Szepietowski, J. C., Tsai, T. F., Hampele, I., You, R., Charef, P., & Papavassilis, C. (2023). Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment: results of a randomized extension of the phase III ERASURE and FIXTURE trials. British Journal of Dermatology, 188(2), 198-207. https://doi.org/10.1093/bjd/ljac040

Langley, RG, Sofen, H, Dei-Cas, I, Reich, K, Sigurgeirsson, B, Warren, RB, Paul, C, Szepietowski, JC, Tsai, TF, Hampele, I, You, R, Charef, P & Papavassilis, C 2023, 'Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment: results of a randomized extension of the phase III ERASURE and FIXTURE trials', British Journal of Dermatology, vol. 188, no. 2, pp. 198-207. https://doi.org/10.1093/bjd/ljac040

@article{76d4060f95a24c0e952a90a9ab879e45,

title = "Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment: results of a randomized extension of the phase III ERASURE and FIXTURE trials",

author = "Langley, {Richard G.} and Howard Sofen and Ignacio Dei-Cas and Kristian Reich and Bardur Sigurgeirsson and Warren, {Richard B.} and Carle Paul and Szepietowski, {Jacek C.} and Tsai, {Tsen Fang} and Isabelle Hampele and Ruquan You and Pascal Charef and Charis Papavassilis",

note = "Publisher Copyright: {\textcopyright} 2022 The Author(s). Published by Oxford University Press on behalf of British Association of Dermatologists.",

year = "2023",

month = feb,

doi = "10.1093/bjd/ljac040",

language = "English",

volume = "188",

pages = "198--207",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Wiley-Blackwell",

number = "2",

}

TY - JOUR

T1 - Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment

T2 - results of a randomized extension of the phase III ERASURE and FIXTURE trials

AU - Langley, Richard G.

AU - Sofen, Howard

AU - Dei-Cas, Ignacio

AU - Reich, Kristian

AU - Sigurgeirsson, Bardur

AU - Warren, Richard B.

AU - Paul, Carle

AU - Szepietowski, Jacek C.

AU - Tsai, Tsen Fang

AU - Hampele, Isabelle

AU - You, Ruquan

AU - Charef, Pascal

AU - Papavassilis, Charis

PY - 2023/2

Y1 - 2023/2

UR - http://www.scopus.com/inward/record.url?scp=85147894504&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85147894504&partnerID=8YFLogxK

U2 - 10.1093/bjd/ljac040

DO - 10.1093/bjd/ljac040

M3 - Article

C2 - 36763857

AN - SCOPUS:85147894504

SN - 0007-0963

VL - 188

SP - 198

EP - 207

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 2

ER -

Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment: results of a randomized extension of the phase III ERASURE and FIXTURE trials

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this